Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, c/o 2ª Medicina, Spedali Civili, 25100, Brescia, Italy.
Chair of Ophthalmology, University of Brescia, Brescia, Italy.
Intern Emerg Med. 2017 Oct;12(7):963-974. doi: 10.1007/s11739-017-1696-7. Epub 2017 Jun 24.
Dihydropyridine calcium channel blockers may possess antioxidant properties, and might improve micro and macrovascular structure and function. Combination treatment with an ACE inhibitor may have additional advantages, compared with a thiazide diuretic. The aim of the present study is to investigate the effects of a short-term treatment with lercanidipine, and to compare two combination treatments: lercanidipine + enalapril vs. lercanidipine + hydrochlorothiazide on structural alterations in retinal arterioles, on skin capillary density and on large artery distensibility. Thirty essential hypertension patients are included in the study, and treated for 4 weeks with lercanidipine 20 mg per day orally. Then, they were treated for 6 months with lercanidipine + enalapril (n = 15) or lercanidipine + hydrochlorothiazide (n = 15) combinations. Investigations were performed on basal condition, after appropriate wash out of previous treatments, after 4 weeks of lercanidipine monotherapy treatment, and at the end of the combination treatment. Non-invasive measurements of wall-to-lumen ratio (WLR) and other morphological parameters of retinal arterioles were performed using either scanning laser Doppler flowmetry or adaptive optics. Capillary density was evaluated by capillaroscopy, while pulse wave velocity was measured, and central blood pressures were assessed by pressure waveform analysis. A significant improvement of WLR and other indices of retinal artery structure is observed with both technical approaches after treatment with lercanidipine alone, with a further improvement after treatment with lercanidipine + enalapril, while after treatment with lercanidipine + hydrochlorothiazide, the improvement is partially blunted. Central systolic and diastolic blood pressures are similarly reduced by both therapeutic strategies. Capillary density is increased only after treatment with lercanidipine + enalapril. In conclusion, lercanidipine both in monotherapy and in combination with enalapril but not with hydrochlorothiazide is able to improve microvascular structure; on the other hand, a decrease in central blood pressure is observed with both therapeutic combinations.
二氢吡啶钙通道阻滞剂可能具有抗氧化特性,并可能改善微血管和大血管的结构和功能。与噻嗪类利尿剂相比,与 ACE 抑制剂联合治疗可能具有额外的优势。本研究旨在探讨短期应用氨氯地平的治疗效果,并比较两种联合治疗方案:氨氯地平+依那普利与氨氯地平+氢氯噻嗪对视网膜小动脉结构改变、皮肤毛细血管密度和大动脉顺应性的影响。将 30 例原发性高血压患者纳入研究,并给予氨氯地平 20mg/d 口服治疗 4 周。然后,他们接受氨氯地平+依那普利(n=15)或氨氯地平+氢氯噻嗪(n=15)联合治疗 6 个月。在基础状态、适当洗脱先前治疗后、氨氯地平单药治疗 4 周后以及联合治疗结束时进行检查。使用扫描激光多普勒血流仪或自适应光学仪对视网膜小动脉的壁腔比(WLR)和其他形态参数进行非侵入性测量。毛细血管密度通过毛细血管镜评估,而脉搏波速度通过压力波分析进行测量,中心血压通过评估。单独使用氨氯地平治疗后,两种技术方法均观察到 WLR 和其他视网膜动脉结构指标显著改善,联合使用氨氯地平+依那普利治疗后进一步改善,而联合使用氨氯地平+氢氯噻嗪治疗后,改善部分减弱。两种治疗策略均可降低中心收缩压和舒张压。仅在使用氨氯地平+依那普利治疗后,毛细血管密度才增加。总之,氨氯地平无论是单独使用还是与依那普利联合使用(而非与氢氯噻嗪联合使用)都能改善微血管结构;另一方面,两种治疗联合方案均可降低中心血压。